Operationalizing diagnostic criteria for Alzheimer’s disease and other age-related cognitive impairment—Part 2

[1]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[2]  M. Sugishita,et al.  [Clinical Dementia Rating (CDR)]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.

[3]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[4]  S. Leurgans,et al.  Sources of variability in estimates of the prevalence of Alzheimer’s disease in the United States , 2011, Alzheimer's & Dementia.

[5]  J. Morris,et al.  Operationalizing diagnostic criteria for Alzheimer’s disease and other age-related cognitive impairment—Part 1 , 2011, Alzheimer's & Dementia.

[6]  R. Brookmeyer,et al.  National estimates of the prevalence of Alzheimer’s disease in the United States , 2011, Alzheimer's & Dementia.

[7]  E G Tangalos,et al.  Prevalence of mild cognitive impairment is higher in men , 2010, Neurology.

[8]  Christopher Kircher.  COGNITIVE DECLINE IN INCIDENT ALZHEIMER DISEASE IN A COMMUNITY POPULATION , 2010, Neurology.

[9]  M. Donohue,et al.  Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment , 2010, Neurobiology of Aging.

[10]  Ronald C Petersen,et al.  Alzheimer's disease: progress in prediction , 2010, The Lancet Neurology.

[11]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.

[12]  Ron Brookmeyer,et al.  Dementia incidence continues to increase with age in the oldest old: The 90+ study , 2010, Annals of neurology.

[13]  Carol Brayne,et al.  Age, neuropathology, and dementia. , 2009, The New England journal of medicine.

[14]  C. Jack,et al.  Mild cognitive impairment: ten years later. , 2009, Archives of neurology.

[15]  M. Weiner,et al.  Relationships between biomarkers in aging and dementia , 2009, Neurology.

[16]  Nick C Fox,et al.  Conversion of amyloid positive and negative MCI to AD over 3 years , 2009, Neurology.

[17]  M. Sarazin,et al.  Faculty Opinions recommendation of Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. , 2009 .

[18]  S. Leurgans,et al.  The neuropathology of probable Alzheimer disease and mild cognitive impairment , 2009, Annals of neurology.

[19]  Magda Tsolaki,et al.  Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study , 2009, The Lancet Neurology.

[20]  R. Petersen,et al.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects , 2009, Annals of neurology.

[21]  D. Berlau,et al.  APOE ε2 is associated with intact cognition but increased Alzheimer pathology in the oldest old , 2009, Neurology.

[22]  D. Bennett,et al.  The neuropathology of older persons with and without dementia from community versus clinic cohorts. , 2009, Journal of Alzheimer's disease : JAD.

[23]  W. Markesbery,et al.  Characterization of Japanese-American men with a single neocortical AD lesion type , 2008, Neurobiology of Aging.

[24]  J. Bond,et al.  Two‐Year Progression from Mild Cognitive Impairment to Dementia: To What Extent Do Different Definitions Agree? , 2008, Journal of the American Geriatrics Society.

[25]  R Brookmeyer,et al.  Prevalence of dementia after age 90 , 2008, Neurology.

[26]  S. DeKosky,et al.  Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease , 2008, Brain : a journal of neurology.

[27]  V. Pankratz,et al.  The Mayo Clinic Study of Aging: Design and Sampling, Participation, Baseline Measures and Sample Characteristics , 2008, Neuroepidemiology.

[28]  Sudha Seshadri,et al.  Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study , 2007, The Lancet Neurology.

[29]  L. Mercy,et al.  The Medical Research Council Cognitive Function and Ageing Study , 2007 .

[30]  K. Welsh-Bohmer,et al.  Duke Twins Study of Memory in Aging in the NAS-NRC Twin Registry , 2006, Twin Research and Human Genetics.

[31]  K. Welsh-Bohmer,et al.  Duke Twins Study of Memory in Aging in the NAS-NRC Twin Registry. , 2006, Twin research and human genetics : the official journal of the International Society for Twin Studies.

[32]  E. Tangalos,et al.  Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. , 2006, Archives of neurology.

[33]  P. Wolf,et al.  The lifetime risk of stroke: estimates from the Framingham Study. , 2006, Stroke.

[34]  David C. Steffens,et al.  Comparison of clinical and neuropathologic diagnoses of Alzheimer’s disease in 3 epidemiologic samples , 2006, Alzheimer's & Dementia.

[35]  K. Langa,et al.  The Aging, Demographics, and Memory Study: Study Design and Methods , 2005, Neuroepidemiology.

[36]  Zaven S. Khachaturian,et al.  Diagnosis of Alzheimer’s disease: Two decades of progress* , 2005, Alzheimer's & Dementia.

[37]  C. Jack,et al.  Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.

[38]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[39]  Keith A. Johnson,et al.  Neuropathology of Cognitively Normal Elderly , 2003, Journal of neuropathology and experimental neurology.

[40]  D. Bennett,et al.  Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status. , 2003, Archives of neurology.

[41]  R. Hu.  Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) , 2003 .

[42]  W. Satariano,et al.  Causes and consequences of comorbidity: a review. , 2001, Journal of clinical epidemiology.

[43]  J. Guralnik,et al.  Documented head injury in early adulthood and risk of Alzheimer’s disease and other dementias , 2000, Neurology.

[44]  R B D'Agostino,et al.  Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. , 2000, Statistics in medicine.

[45]  R Brookmeyer,et al.  Age-specific incidence rates of Alzheimer’s disease , 2000, Neurology.

[46]  Roberta F. White,et al.  The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. , 2000, Archives of neurology.

[47]  R. Lipton,et al.  The relative frequency of "dementia of unknown etiology" increases with age and is nearly 50% in nonagenarians. , 2000, Archives of neurology.

[48]  H. Cohen,et al.  Comorbidity of five chronic health conditions in elderly community residents: determinants and impact on mortality. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.

[49]  R. Mayeux,et al.  A clinicopathological comparison of community-based and clinic-based cohorts of patients with dementia. , 1999, Archives of neurology.

[50]  M. Albert,et al.  Change in cognitive function in older persons from a community population: relation to age and Alzheimer disease. , 1999, Archives of neurology.

[51]  I G McKeith,et al.  Report of the second dementia with Lewy body international workshop , 1999, Neurology.

[52]  K. Welsh-Bohmer,et al.  APOE-ε4 count predicts age when prevalence of AD increases, then declines , 1999, Neurology.

[53]  Linda Teri,et al.  Clinico‐Neuropathological Correlation of Alzheimer's Disease in a Community‐Based Case Series , 1999, Journal of the American Geriatrics Society.

[54]  F. Schmitt,et al.  Alzheimer neuropathologic alterations in aged cognitively normal subjects. , 1999, Journal of neuropathology and experimental neurology.

[55]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[56]  B W Wyse,et al.  APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. , 1999, Neurology.

[57]  R Brookmeyer,et al.  Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. , 1998, American journal of public health.

[58]  A D Roses,et al.  Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. , 1998, The New England journal of medicine.

[59]  R B D'Agostino,et al.  Lifetime risk of dementia and Alzheimer's disease , 1997, Neurology.

[60]  K. Boone,et al.  A study of the Lund‐Manchester research criteria for frontotemporal dementia , 1997, Neurology.

[61]  M. Folstein,et al.  Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans. III. Detection of cases, longitudinal results, and observations on twin concordance. , 1995, Archives of neurology.

[62]  L A Beckett,et al.  Age-specific incidence of Alzheimer's disease in a community population. , 1995, JAMA.

[63]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology Confirmation of the Clinical Diagnosis of Alzheimer's Disease , 1995, Neurology.

[64]  R B D'Agostino,et al.  Incidence of dementia and probable Alzheimer's disease in a general population , 1993, Neurology.

[65]  W. Jagust,et al.  Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers , 1992, Neurology.

[66]  R. D'Agostino,et al.  Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study , 1992, Neurology.

[67]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[68]  M. Albert,et al.  Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. , 1991, The International journal of neuroscience.

[69]  P. Allhoff,et al.  The Framingham Offspring Study , 1991 .

[70]  M. Albert,et al.  Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. , 1989, JAMA.

[71]  K P Offord,et al.  Prevalence of medically diagnosed dementia in a defined United States population , 1989, Neurology.

[72]  H Morgenstern,et al.  Development of dementing illnesses in an 80‐year‐old volunteer cohort , 1989, Annals of neurology.

[73]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[74]  E. Kaplan,et al.  Neuropsychological test performance in Framingham: a descriptive study. , 1987, Psychological reports.

[75]  Laurence H. Baker,et al.  Clinical Trials: Design, Conduct, and Analysis , 1987 .

[76]  L. Berg,et al.  Clinical Dementia Rating , 1984, British Journal of Psychiatry.

[77]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[78]  C. Eisdorfer,et al.  Diagnostic criteria for primary neuronal degeneration of the Alzheimer's type. , 1980, The Journal of family practice.

[79]  W. Kannel,et al.  The Framingham Offspring Study. Design and preliminary data. , 1975, Preventive medicine.

[80]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[81]  M. Roth,et al.  The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects , 1968, British Journal of Psychiatry.

[82]  W. Kannel,et al.  The Framingham Study An Epidemiological Approach to Coronary Heart Disease , 1966, Circulation.